Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2003
05/21/2003EP0877752B1 Methods for screening for transdominant effector peptides and rna molecules
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0820337B1 Centrifugal fermentation process
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419599A Method for transforming plant plastides and making transplastomic plants
05/21/2003CN1419598A Detection of immunological memory, T-cell conjugates for pathology imaging and therapy
05/21/2003CN1419597A Simultaneous stimulation and concentration of cells
05/21/2003CN1419413A Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
05/21/2003CN1419409A Methods for gamete production in birds
05/21/2003CN1418954A High temp. resistant HSP 70 molecular chaperone and coded polypeptide and preparation process thereof
05/21/2003CN1418950A Method for obtaining haploid plant strain by culturing anther or pollen
05/20/2003WO2003044037A2 Process for the manufacture of human mononuclear phagocytic leukocytes
05/20/2003US6566587 Mutated 5-enolpyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene
05/20/2003US6566585 Transgenic plant cell for use in the generation of heterologous proteins
05/20/2003US6566583 Schizochytrium PKS genes
05/20/2003US6566582 Animal model for use in the diagnosis and treatment of cancer
05/20/2003US6566581 Animal model for use in the diagnosis and treatment of lung cancer
05/20/2003US6566505 Antibodies to Mch6 polypeptides
05/20/2003US6566499 Adipocyte-specific protein homologs
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566342 Genetic engineering
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6566136 Immortalized cell line derived from normal human skin tissues
05/20/2003US6566131 Antisense modulation of Smad6 expression
05/20/2003US6566128 Generation of preferential expression vectors; obtain cells, transform with adenoviral vector, propagate and recover adenovirus virions
05/20/2003US6566127 Enzymatic nucleic acid for use in the treatment of tumors, vision defects, arthritis and skin disorders
05/20/2003US6566126 Cell-culture medium passes through the lumen of a hollow fiber and to pass nutrients through the walls of the hollow fiber to the cells in the extra-capillary space; rocking or rotation effects flow through gravity
05/20/2003US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
05/20/2003US6566116 Enzymatic polypeptide for use in the treatment of diabetic nephropathy, glomerulonephritis, fibrosis, liver and kidney disorders, osteoporosis and lung disorders
05/20/2003US6566114 Mannanases
05/20/2003US6566110 Nucleotide sequences coding polypeptide for use tool in halogenating compounds
05/20/2003US6566109 Gene for thermostable glucokinase, recombinant vector containing the same, transformant containing the recombinant vector and process for producing thermostable glucokinase using the transformant
05/20/2003US6566099 Nucleotide sequences coding polypeptide for use in the treatment of lysosomal storage disease
05/20/2003US6566096 Mammalian EDG-7 receptor homologs
05/20/2003US6566095 Blocking transmission of viral particles to animals; obtain animal, administer antibody, incubate with viral sample, monitor viral infection, reduction in viral infection indicates antagonist
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/20/2003US6566089 Cell-based drug screens for regulators of gene expression
05/20/2003US6566087 Detection of preferential enzymatic polypeptide; obtain sample containing enzymatic polypeptide, expose to modulator, monitor binding, detect adjustment in enzyme activity
05/20/2003US6566075 Methods for detecting human platelet-derived growth factor receptor agonists and antagonists
05/20/2003US6566073 Materials and methods involving conditional retention domains
05/20/2003US6566066 Aquaporin-8 variant
05/20/2003US6566063 Diagnosing cancer in cells; obtain cells, monitor expression of gland-specific transcription factor, compare to control, evaluate for cancer
05/20/2003US6566057 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565845 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains
05/20/2003US6565844 Protein production and protein delivery
05/20/2003US6565843 Protein-induced tissue morphogenesis
05/20/2003US6565842 Crosslinking gel
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/20/2003CA2075695C Monoclonal antibodies to sulfonated polymers
05/16/2003CA2409317A1 Method of enhancing self renewal of stem cells and uses thereof
05/15/2003WO2003040686A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
05/15/2003WO2003040377A1 Method fro selecting genetically transformed cells
05/15/2003WO2003040363A1 Rice transposon genes
05/15/2003WO2003040359A1 Preparing somatic embryo by utilizing rabbit oocyte
05/15/2003WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells
05/15/2003WO2003040355A1 Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom
05/15/2003WO2003040354A1 Capacitative calcium entry mechanism in porcine oocytes
05/15/2003WO2003040353A1 A novel stem cell with long-term growth potential, methods of culturing and animals derived therefrom
05/15/2003WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003WO2003040341A2 Anti-hepatitis a virus antibodies
05/15/2003WO2003040340A2 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/15/2003WO2003040337A2 Polyamide modulators of cox2 transcription
05/15/2003WO2003040336A2 Stem and progenitor cell capture for tissue regeneration
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040324A2 Methods for mutating genes in cells and animals using insertional mutagenesis
05/15/2003WO2003040322A2 Promoters for regulation of gene expression in plant roots
05/15/2003WO2003040319A2 Endothelial cells derived from primate embryonic stem cells
05/15/2003WO2003040316A2 Selective elimination of cd52+ cells and uses thereof
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040300A2 Transportable contractile nerve-muscle co-culture
05/15/2003WO2003040298A2 Cell and tissue growth using substances that reversibly bind oxygen
05/15/2003WO2003040296A2 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003039611A1 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on
05/15/2003WO2003039575A2 Use of reelin, gas6, and protein s in the treatment of neural disorders
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039489A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003WO2003039484A2 Novel compositions and methods for cancer
05/15/2003WO2003039481A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039471A2 Catalytic antibodies raised against sarin and process for the preparation thereof
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039404A2 Methods for treating ocular neovascular diseases
05/15/2003WO2003039382A2 System for processing tissue
05/15/2003WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003WO2003039311A1 Stem cell and dental pulp harvesting method and apparatus
05/15/2003WO2003039273A1 Molecular press dehydration method for vegetative tissue using the solid phase of water soluble polymer substances as a dehydrating agent
05/15/2003WO2003039245A2 Transgenic mice knockout for histamine receptor h3 gene
1 ... 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 ... 1827